Androgen receptor independent cardiovascular action of the antiandrogen flutamide

[1]  R. Iliescu,et al.  Abolition of End-Organ Damage by Antiandrogen Treatment in Female Hypertensive Transgenic Rats , 2003, Hypertension.

[2]  R. Iliescu,et al.  Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene. , 2002, Journal of the American Society of Nephrology : JASN.

[3]  Z. Ba,et al.  Flutamide induces relaxation in large and small blood vessels. , 2002, Archives of surgery.

[4]  A. Morice,et al.  Pulmonary Vasodilatory Action of Testosterone: Evidence of a Calcium Antagonistic Action , 2002, Journal of cardiovascular pharmacology.

[5]  D. Kendall,et al.  Testosterone‐induced vasorelaxation in the rat mesenteric arterial bed is mediated predominantly via potassium channels , 2002, British journal of pharmacology.

[6]  A. Ding,et al.  Testosterone-induced relaxation of rat aorta is androgen structure specific and involves K+ channel activation. , 2001, Journal of applied physiology.

[7]  V. Deenadayalu,et al.  Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel. , 2001, American journal of physiology. Heart and circulatory physiology.

[8]  J F Reckelhoff,et al.  Gender Differences in the Regulation of Blood Pressure , 2001, Hypertension.

[9]  C. Hayward,et al.  Effect of sex hormones on cardiac mass , 2001, The Lancet.

[10]  D. Seachrist,et al.  Sodium-induced rise in blood pressure is suppressed by androgen receptor blockade. , 2001, American journal of physiology. Heart and circulatory physiology.

[11]  D. Ganten,et al.  Alterations in Blood Pressure and Heart Rate Variability in Transgenic Rats With Low Brain Angiotensinogen , 2001, Hypertension.

[12]  P. Huang,et al.  An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Helmut Klocker,et al.  Rapid signalling by androgen receptor in prostate cancer cells , 1999, Oncogene.

[14]  M. Feneley,et al.  Response of the intact canine left ventricle to increased afterload and increased coronary perfusion pressure in the presence of coronary flow autoregulation. , 1999, Circulation.

[15]  S. Andò,et al.  Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor alpha. , 1999, Cancer research.

[16]  J. Granger,et al.  Gender differences in hypertension in spontaneously hypertensive rats: role of androgens and androgen receptor. , 1999, Hypertension.

[17]  R. Busse,et al.  Signal transduction of eNOS activation. , 1999, Cardiovascular research.

[18]  J. Granger,et al.  ROLE OF ANDROGENS IN MEDIATING HYPERTENSION AND RENAL INJURY , 1999, Clinical and experimental pharmacology & physiology.

[19]  R. Karas,et al.  Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. , 1999, The Journal of clinical investigation.

[20]  T. Kumai,et al.  Effects of anti-androgen treatment on the catecholamine synthetic pathway in the adrenal medulla of spontaneously hypertensive rats , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

[21]  J. Ménard,et al.  Mouse and rat plasma renin concentration and gene expression in (mRen2)27 transgenic rats. , 1998, The American journal of physiology.

[22]  R. Busse,et al.  Calcium-dependent and calcium-independent activation of the endothelial NO synthase. , 1997, Journal of vascular research.

[23]  F. Whittier,et al.  Testosterone causes direct relaxation of rat thoracic aorta. , 1996, The Journal of pharmacology and experimental therapeutics.

[24]  P. Poole‐Wilson,et al.  Testosterone relaxes rabbit coronary arteries and aorta. , 1995, Circulation.

[25]  S. Oparil,et al.  Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. , 1992, Hypertension.

[26]  R. N. Brogden,et al.  Flutamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in advanced prostatic cancer. , 1991, Drugs & aging.

[27]  B. Grubb,et al.  Clinical signs of androgen excess as risk factors for coronary artery disease. , 1990, Fertility and sterility.

[28]  D. Ganten,et al.  Sexual dimorphism of blood pressure in spontaneously hypertensive rats: effects of anti-androgen treatment. , 1989, Journal of hypertension.

[29]  H. Baer,et al.  Relaxant effects of forskolin in smooth muscle , 1983, Naunyn-Schmiedeberg's Archives of Pharmacology.

[30]  D. E. Gregg,et al.  Effect of Coronary Perfusion Pressure or Coronary Flow on Oxygen Usage of the Myocardium , 1963, Circulation research.

[31]  O. Langendorff,et al.  Untersuchungen am überlebenden Säugethierherzen , 1895, Archiv für die gesamte Physiologie des Menschen und der Tiere.

[32]  J F Reckelhoff,et al.  Gender differences in development of hypertension in spontaneously hypertensive rats: role of the renin-angiotensin system. , 2000, Hypertension.

[33]  G. Morgante,et al.  Hormonal effects of flutamide in young women with polycystic ovary syndrome. , 1998, The Journal of clinical endocrinology and metabolism.

[34]  A. Cittadini,et al.  Validation of different methods to compare isovolumic cardiac function in isolated hearts of varying sizes. , 1997, The American journal of physiology.